Recombinant dna-vector comprising genomic equine arteritis...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/86 (2006.01) A61K 31/70 (2006.01) A61K 48/00 (2006.01) C07K 14/165 (2006.01) C12N 5/10 (2006.01) C12N 7/01 (2006.01)

Patent

CA 2259964

The present invention relates to a recombinant DNA vector comprising a cDNA copy of at least a part of the genome of equine arteritis virus. The recombinant DNA vector according to the present invention is stable in a vector host cell and yields, after transcription, infectious RNA. Due to the invention the genetic engineering of the virus is very much simplified and it may be used for, among other things, the preparation of pharmaceutical compositions. Licensing possible.

L'invention a pour objet un vecteur d'ADN recombiné contenant une copie ANDc d'au moins une partie du génome du virus equine arteritis. Le vecteur d'ADN recombiné conforme à l'invention, stable dans une cellule hôte du vecteur, produit, après transcription, un ARN infectieux. Grâce à l'invention, l'obtention par génie génétique du virus est de beaucoup simplifiée. Ledit virus peut être utilisé, notamment, pour la préparation de compositions pharmaceutiques. Obtention de licence possible.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant dna-vector comprising genomic equine arteritis... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant dna-vector comprising genomic equine arteritis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant dna-vector comprising genomic equine arteritis... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1949952

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.